Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 19 | 2024 | 1071 | 2.450 |
Why?
|
| Shock, Cardiogenic | 3 | 2024 | 178 | 2.060 |
Why?
|
| Heart Failure | 25 | 2025 | 2385 | 1.990 |
Why?
|
| Ventricular Function, Left | 10 | 2020 | 548 | 1.460 |
Why?
|
| Myocardium | 9 | 2019 | 906 | 1.340 |
Why?
|
| Heart Ventricles | 9 | 2018 | 785 | 1.030 |
Why?
|
| Myocardial Ischemia | 6 | 2019 | 342 | 0.960 |
Why?
|
| Cardiomyopathies | 5 | 2019 | 510 | 0.910 |
Why?
|
| Cytokines | 2 | 2021 | 1359 | 0.910 |
Why?
|
| Proteome | 2 | 2024 | 279 | 0.880 |
Why?
|
| Recovery of Function | 5 | 2017 | 461 | 0.840 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 240 | 0.770 |
Why?
|
| Biomarkers | 5 | 2024 | 3405 | 0.700 |
Why?
|
| Hemodynamics | 4 | 2024 | 850 | 0.690 |
Why?
|
| Oxygenators, Membrane | 1 | 2020 | 8 | 0.690 |
Why?
|
| Proteomics | 1 | 2024 | 596 | 0.630 |
Why?
|
| Inflammation | 3 | 2024 | 1519 | 0.620 |
Why?
|
| Lymphocytes | 1 | 2020 | 362 | 0.600 |
Why?
|
| Neutrophils | 1 | 2020 | 361 | 0.570 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2015 | 129 | 0.520 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 655 | 0.520 |
Why?
|
| Diastole | 2 | 2015 | 181 | 0.460 |
Why?
|
| Ventricular Remodeling | 4 | 2020 | 167 | 0.460 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2015 | 376 | 0.450 |
Why?
|
| Coronary Circulation | 4 | 2015 | 206 | 0.330 |
Why?
|
| Machine Learning | 2 | 2025 | 345 | 0.310 |
Why?
|
| Middle Aged | 23 | 2025 | 28947 | 0.300 |
Why?
|
| Time Factors | 9 | 2024 | 6440 | 0.290 |
Why?
|
| Myocardial Contraction | 4 | 2017 | 255 | 0.270 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2025 | 50 | 0.250 |
Why?
|
| RNA | 2 | 2023 | 552 | 0.240 |
Why?
|
| Heart Transplantation | 3 | 2021 | 877 | 0.230 |
Why?
|
| Mitochondria, Heart | 2 | 2016 | 53 | 0.230 |
Why?
|
| Male | 25 | 2025 | 64877 | 0.230 |
Why?
|
| Humans | 34 | 2025 | 131934 | 0.220 |
Why?
|
| No-Reflow Phenomenon | 2 | 2015 | 9 | 0.220 |
Why?
|
| Aged | 13 | 2025 | 21390 | 0.210 |
Why?
|
| Prospective Studies | 8 | 2025 | 6569 | 0.210 |
Why?
|
| Wearable Electronic Devices | 1 | 2025 | 107 | 0.210 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 660 | 0.210 |
Why?
|
| Blood Proteins | 1 | 2024 | 137 | 0.200 |
Why?
|
| Coronary Vessels | 2 | 2019 | 548 | 0.200 |
Why?
|
| Cardiomegaly | 2 | 2020 | 125 | 0.200 |
Why?
|
| Female | 22 | 2025 | 70592 | 0.200 |
Why?
|
| Treatment Outcome | 8 | 2024 | 12995 | 0.180 |
Why?
|
| Tuberculosis, Miliary | 1 | 2021 | 10 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2023 | 433 | 0.170 |
Why?
|
| Prognosis | 4 | 2021 | 5007 | 0.170 |
Why?
|
| Anion Transport Proteins | 1 | 2020 | 31 | 0.170 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 37 | 0.170 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 119 | 0.170 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 58 | 0.170 |
Why?
|
| Echocardiography | 5 | 2019 | 1129 | 0.160 |
Why?
|
| Prosthesis Design | 2 | 2020 | 666 | 0.160 |
Why?
|
| Heart, Artificial | 1 | 2020 | 69 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 77 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 158 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2021 | 534 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 664 | 0.150 |
Why?
|
| Vasodilation | 1 | 2019 | 182 | 0.150 |
Why?
|
| Cardiology | 1 | 2023 | 498 | 0.140 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 295 | 0.140 |
Why?
|
| Muscle Proteins | 1 | 2020 | 406 | 0.140 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 13 | 0.130 |
Why?
|
| Apoptosis | 1 | 2024 | 1891 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 5408 | 0.130 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 363 | 0.130 |
Why?
|
| Swine | 3 | 2015 | 1181 | 0.130 |
Why?
|
| Stroke Volume | 5 | 2025 | 538 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 88 | 0.130 |
Why?
|
| Atrial Appendage | 1 | 2017 | 76 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 1046 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 487 | 0.130 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 56 | 0.120 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1057 | 0.120 |
Why?
|
| Insulin | 1 | 2020 | 1168 | 0.110 |
Why?
|
| Dabigatran | 1 | 2015 | 29 | 0.110 |
Why?
|
| Arterial Pressure | 1 | 2015 | 127 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2312 | 0.110 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2014 | 44 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2014 | 24 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 3087 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 38 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 336 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2015 | 93 | 0.110 |
Why?
|
| Atrophy | 1 | 2014 | 251 | 0.110 |
Why?
|
| Ubiquitin | 1 | 2014 | 140 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 131 | 0.110 |
Why?
|
| Adult | 8 | 2024 | 31538 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2014 | 218 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2025 | 1003 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2020 | 3733 | 0.100 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 59 | 0.100 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 254 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1077 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 540 | 0.090 |
Why?
|
| Heart Failure, Diastolic | 1 | 2012 | 10 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1173 | 0.090 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 18 | 0.090 |
Why?
|
| Aorta | 1 | 2015 | 550 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2014 | 876 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2018 | 1122 | 0.090 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 20 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 439 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2015 | 519 | 0.090 |
Why?
|
| Resistance Training | 1 | 2011 | 32 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2012 | 136 | 0.080 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 1035 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2011 | 91 | 0.080 |
Why?
|
| Animals | 9 | 2020 | 34785 | 0.080 |
Why?
|
| Heart | 2 | 2016 | 690 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 62 | 0.080 |
Why?
|
| Bone Density | 1 | 2012 | 367 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2014 | 785 | 0.080 |
Why?
|
| Biopsy | 3 | 2019 | 1284 | 0.080 |
Why?
|
| Heart Rate | 1 | 2011 | 585 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 571 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2011 | 771 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 892 | 0.070 |
Why?
|
| Cardiac Catheterization | 2 | 2025 | 661 | 0.070 |
Why?
|
| Risk Factors | 1 | 2020 | 10935 | 0.060 |
Why?
|
| Photoplethysmography | 1 | 2025 | 7 | 0.060 |
Why?
|
| Models, Cardiovascular | 2 | 2018 | 184 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17375 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2023 | 13 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2023 | 88 | 0.050 |
Why?
|
| Endothelium | 1 | 2023 | 64 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3139 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3860 | 0.050 |
Why?
|
| Pyrazinamide | 1 | 2021 | 11 | 0.050 |
Why?
|
| Isoniazid | 1 | 2021 | 66 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 45 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2012 | 203 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 38 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 321 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 153 | 0.040 |
Why?
|
| Exercise Test | 2 | 2011 | 258 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2012 | 305 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 62 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 526 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2021 | 264 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2023 | 777 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 514 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 687 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1161 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 67 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 516 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 50 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 118 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3409 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 500 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 343 | 0.030 |
Why?
|
| Mutation | 1 | 2011 | 6227 | 0.030 |
Why?
|
| Free Radicals | 1 | 2016 | 33 | 0.030 |
Why?
|
| Mice | 3 | 2020 | 18461 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1228 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 139 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 408 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 120 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 747 | 0.030 |
Why?
|
| Greece | 1 | 2015 | 11 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 117 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1347 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2015 | 196 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2020 | 698 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 246 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2014 | 18 | 0.030 |
Why?
|
| Electron Transport Complex II | 1 | 2014 | 2 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 123 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 32 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 102 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1721 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 602 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 124 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2719 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 303 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 754 | 0.020 |
Why?
|
| Phenotype | 2 | 2014 | 4526 | 0.020 |
Why?
|
| Systole | 1 | 2013 | 206 | 0.020 |
Why?
|
| Fibrosis | 1 | 2014 | 421 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1280 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3608 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 83 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 1331 | 0.020 |
Why?
|
| KRIT1 Protein | 1 | 2011 | 1 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 277 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 128 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 697 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4752 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 252 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1881 | 0.020 |
Why?
|
| Anaerobic Threshold | 1 | 2011 | 11 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 435 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 130 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 152 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2011 | 87 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 169 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2011 | 89 | 0.020 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Vitamin D | 1 | 2012 | 183 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2010 | 37 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 154 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2015 | 608 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 257 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 589 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 282 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 170 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 295 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 986 | 0.020 |
Why?
|
| Body Composition | 1 | 2011 | 550 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 412 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 9952 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 613 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2010 | 342 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3376 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1017 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 1233 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2221 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 2444 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11650 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4682 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2697 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 858 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 3175 | 0.010 |
Why?
|